Form 4: CalciMedica Director Allan Shaw Acquires Stock Options
SEC Form 4 Filing
Director Allan Shaw acquired stock options for 10,000 shares of CalciMedica, Inc. at an exercise price of $4.16 on March 28, 2024.
Summary
- On March 28, 2024, Allan Shaw, a director of CalciMedica, Inc., acquired stock options to purchase 10,000 shares of the company's common stock.
- The exercise price of the options is $4.16 per share.
- The options vest in equal monthly installments over a one-year period following the grant date.
- The options expire on March 27, 2034.
- Following the transaction, Shaw directly owns options for 10,000 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing the acquisition of stock options by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This provides transparency to the market.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of transaction: Allan Shaw acquired stock options. |
| 03/27/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.